DropGenie
Making Personalized Possible
Cambridge, United States · Founded 2018
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- drop-genie.com
- Last Round
- SeedMay 2020
- Rounds
- 2
About
DropGenie builds patented chip-based lab automation technology that miniaturizes and parallelizes cell engineering reactions using electrostatic forces — no pumps, no oils. The platform achieves 100x miniaturization, 40x cost reduction, and 100x speed improvement versus conventional methods. It delivers any editing reagent (mRNA, DNA, proteins) into any cell type at nanoliter volumes, enabling arrayed CRISPR screening in precious primary immune cells, optimization of CAR-T and TCR therapies, and large-scale functional validation of AI-predicted drug targets. DropGenie integrates with standard SBS-format automation systems and is compatible with liquid handlers from partners including Sartorius and Beckman Coulter. The company is headquartered in Cambridge, MA with operations in Montreal, QC.
Summary
DropGenie is a Biotech company based in Cambridge, United States, founded in 2018. Its most recent funding was a Seed round in May 2020. Investors include SOSV.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...